This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Corgenix Announces Contract Manufacturing Agreement With EDP Biotech

Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, announced today that it has entered into a contract manufacturing agreement with EDP Biotech, a medical device company focused on the development and commercialization of immunodiagnostic tests for humans.

Under terms of the 10-year agreement, Corgenix will manufacture and supply the ColoMarker™ diagnostic test, a blood test developed to detect the early stages of colon cancer. Corgenix recently announced the expansion of its Contract Services business unit and launched a dedicated Contract Services website.

“We are pleased to enter into this mutually beneficial relationship with EDP,” said Douglass Simpson, President and CEO of Corgenix. “This reflects our strategic focus on the Contract Services portion of our business for diagnostic products, and it meets the increasing demand overall for contract services in the medical device and biotechnology industries.”

ColoMarker is a simple blood test designed to identify potential cases of early stage colon cancer. ColoMarker requires no advance preparation by the patient such as fasting or colon cleansing and can be added easily to the panel of blood tests routinely performed at a patient’s annual physical.

About EDP Biotech Corporation

EDP Biotech (EDP) is a medical device company focused on the development and sale of human immunodiagnostic tests. EDP utilizes more than 30 years of research and development in the identification and purification of proteins present in the early stages of biological changes for production of in vitro diagnostics test whose primary target is the development of early detection products. For additional information, visit EDP Biotech online at .

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world’s only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience in product submissions to the FDA and other worldwide regulatory authorities. Additionally Corgenix contract develops and manufactures products for key medical and life science companies in state-of-the-art facilities in Colorado. The company operates under a Quality Management System that is ISO 13485:2012 certified and compliant with FDA regulations. More information is available at (Corporate website) and (Contract Services website).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,822.04 +9.85 0.06%
S&P 500 2,091.73 +2.59 0.12%
NASDAQ 5,122.7230 +19.9150 0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs